Befidi Robert's Insider Trades & SAST Disclosures
Befidi Robert's most recent trade in Envista Holdings Corp was a trade of 24,010 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Befidi Robert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | Robert Befidi | President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 24,010 | 24,010 | - | - | Employee Stock Option (Right to Buy) | |
| Envista Holdings Corp | Robert Befidi | President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 18,960 | 18,960 | - | - | Performance Share Unit | |
| Envista Holdings Corp | Robert Befidi | President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 10,290 | 48,958 (0%) | 0% | 0 | Common Stock | |
| Envista Holdings Corp | Robert Befidi | President, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.66 per share. | 25 Feb 2025 | 1,123 | 38,668 (0%) | 0% | 20.7 | 23,201 | Common Stock |
| Envista Holdings Corp | Robert Befidi | President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 1,151 | 1,151 | - | - | Envista deferred contribution programs - Envista Stock Fund | |
| Envista Holdings Corp | Robert Befidi | President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2024 | 70,400 | 70,400 | - | - | Performance Option | |
| Envista Holdings Corp | Robert Befidi | President, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.70 per share. | 25 Aug 2024 | 3,454 | 39,791 (0%) | 0% | 18.7 | 64,590 | Common Stock |
| Envista Holdings Corp | Befidi Robert | President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2024 | 21,910 | 21,910 | - | - | Employee Stock Option (Right to Buy) | |
| Envista Holdings Corp | Robert Befidi | President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2024 | 17,260 | 17,260 | - | - | Performance Share Unit | |
| Envista Holdings Corp | Befidi Robert | President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2024 | 9,385 | 43,245 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges